Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CCR7 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB197RSP
This item is not returnable.
View return policy
Description
CCR7 Monoclonal specifically detects CCR7 in Human samples. It is validated for Flow Cytometry, Neutralization, CyTOF-ready.Specifications
CCR7 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. | |
BLR2, BLR2C-C chemokine receptor type 7, C-C CKR-7, CC-CKR-7, CCR7, CCR-7, CD197, CD197 antigen, CDw197, CDw197CC chemokine receptor 7, chemokine (C-C motif) receptor 7, CMKBR7, CMKBR7chemokine (C-C) receptor 7, EBI1, EBI1EBV-induced G protein-coupled receptor 1, EBV-induced G-protein coupled receptor 1, Epstein-Barr virus induced gene 1, Epstein-Barr virus induced G-protein coupled receptor, Epstein-Barr virus-induced G-protein coupled receptor 1, EVI1, lymphocyte-specific G protein-coupled peptide receptor, MIP-3 beta receptor | |
Human CCR7 transfectants Met1-Pro378 Accession # AAA58615 | |
25 μg | |
1236 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Flow Cytometry, Neutralization, CyTOF | |
150503R | |
Flow Cytometry 0.25 ug/10^6 cells, Neutralization 1-5 ug/mL, CyTOF-ready | |
AAA58615 | |
Mouse | |
Protein A or G purified from cell culture supernatant | |
Primary | |
Detects human CCR7. | |
Human | |
Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction